As of April 2024 Rocket Pharmaceuticals has a market cap of $2.14 Billion. This makes Rocket Pharmaceuticals the world's 3983th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $2.14 B | -20.72% |
2023 | $2.70 B | 75.38% |
2022 | $1.54 B | 9.52% |
2021 | $1.40 B | -57.16% |
2020 | $3.28 B | 163.42% |
2019 | $1.24 B | 86.11% |
2018 | $0.66 B | 842.68% |
2017 | $71.05 M | -56.75% |
2016 | $0.16 B | -45.13% |
2015 | $0.29 B |
On Apr 24th, 2024 the market cap of Rocket Pharmaceuticals was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | $0.59 B | -72.42% | ๐บ๐ธ USA |